We are live on ! Find out more
CCA

Conservest Capital Advisors Portfolio holdings

AUM $1.26B
1-Year Est. Return 24.75%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+24.75%
3 Year Est. Return
+58.59%
5 Year Est. Return
+58.69%
10 Year Est. Return
AUM
$471M
AUM Growth
-$447K
Cap. Flow
-$10.5M
Cap. Flow %
-2.22%
Top 10 Hldgs %
72.27%
Holding
85
New
1
Increased
35
Reduced
26
Closed
3

Sector Composition

Rank Sector Weight
1 Energy 2.58%
2 Communication Services 1.86%
3 Technology 1.54%
4 Consumer Discretionary 1.03%
5 Healthcare 1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HES
76
DELISTED
Hess
HES
$217K 0.05%
4,957
-90
-2% -$4.21K
ONDK
77
DELISTED
On Deck Capital, Inc.
ONDK
$216K 0.05%
46,343
AMX icon
78
America Movil
AMX
$76.1B
$212K 0.05%
13,425
MSFT icon
79
Microsoft
MSFT
$3.45T
$208K 0.04%
3,020
-302
-9% -$20.7K
IBM icon
80
IBM
IBM
$211B
$207K 0.04%
1,410
-28
-2% -$4.22K
AMLP icon
81
Alerian MLP ETF
AMLP
$13B
$136K 0.03%
2,271
-238
-9% -$14.5K
FCSC
82
DELISTED
Fibrocell Science Inc.
FCSC
$67K 0.01%
3,333
FSK icon
83
FS KKR Capital
FSK
$2.96B
-5,641
Closed -$221K
PAA icon
84
Plains All American Pipeline
PAA
$17.3B
-6,363
Closed -$201K
TEVA icon
85
Teva Pharmaceuticals
TEVA
$40.8B
-11,692
Closed -$375K

Similar funds

Conservest Capital Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Conservest Capital Advisors held 85 positions worth $471M, down 0.09% from $471M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 4.7%. Conservest Capital Advisors opened 1 new position and exited 3, leaving the 85-position portfolio largely intact.

By sector, the portfolio is most concentrated in Energy at 2.6% of assets, down from 2.8% a quarter earlier, followed by Communication Services and Technology.

  • Conservest Capital Advisors's largest Q2 2017 buy was Vanguard Health Care ETF: 1,841 shares worth $271K.
  • Conservest Capital Advisors added most to Vanguard FTSE Europe ETF in Q2 2017, an estimated $849K increase.
  • Conservest Capital Advisors's biggest Q2 2017 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $11.9M.
  • Conservest Capital Advisors fully exited Teva Pharmaceuticals in Q2 2017, selling an estimated $375K.
  • Conservest Capital Advisors's ten largest holdings make up 72% of its $471M portfolio in Q2 2017.
  • Conservest Capital Advisors opened 1 new position and closed 3 in Q2 2017.
  • Conservest Capital Advisors's portfolio value fell 0.09% quarter-over-quarter to $471M.

Based on Conservest Capital Advisors's 13F filing for Q2 2017, filed 6 Jul 2017.